Dr Antonio Martorell
Dr Antonio Martorell is a dermatologist at the Hospital de Manises in Valencia, Spain, and an Associate Professor of dermatology at the Catholic University of Valencia. He founded and leads a specialised unit focused mainly on the management of patients with psoriasis, hidradenitis suppurativa and related comorbidities.
Dr Martorell received his degree in medicine and surgery from the University of Valencia and specialised in dermatology at Hospital Instituto Valenciano de Oncología, Valencia, an international reference centre in surgery and oncology.
Dr Martorell’s main scientific areas of interest are psoriasis, hidradenitis suppurativa and hair disorders. His recent research has focused on the epigenetic pathways of hidradenitis suppurativa and skin ultrasound, and he is the founder of the DERMUS Task Force. Dr Martorell has authored 217 PubMed articles and has been the invited speaker for 351 lectures covering topics including psoriasis, hidradenitis suppurativa and skin cancer. He is also the Principal Investigator of over 20 clinical assays in phase II, III and IV clinical trials. In addition, Dr Martorell is the founder and coordinator of the Spanish Working Group on Hidradenitis Suppurativa (GTHS), and since 2022, he has led the innovation and research area of the Spanish Academy of Dermatology and Venereology (AEDV). Dr Martorell is also director of the IADERMA course leading a group focused on eHealth oriented to the development of ICT solutions with the aim of improving basic medical procedures during this new technological era. Dr Martorell holds the position of health manager and project coordinator at E-health in SKIANA®.
The first part of the workshop highlights the role of shared decision-making for personalised care in women of childbearing age affected by psoriasis and PsA....
The workshop highlights the challenges and treatment considerations with psoriasis and HS that go beyond the skin. Underlying disease pathophysiology, including...
The speakers discuss the continued unmet needs of patients with inflammatory diseases of skin and joints in terms of treatment outcomes and health-related...
This session reviews the chronic inflammation and pathophysiology of HS, highlighting the association between patients with inflammatory arthritis and HS. The...
This session focuses on the pathobiological relationship between psoriasis and psoriatic arthritis (PsA), how transition from psoriasis to PsA occurs, as well as...
In this session, our speakers explore the inflammatory pathways in immune-mediated inflammatory disease in the context of the evolving treatment considerations...